Supernus Pharmaceuticals, Inc.
SUPN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $151 | $145 | $116 | $69 |
| Short-Term Investments | $130 | $378 | $348 | $384 |
| Receivables | $171 | $141 | $146 | $142 |
| Inventory | $79 | $44 | $49 | $54 |
| Other Curr. Assets | $62 | $31 | $29 | $36 |
| Total Curr. Assets | $594 | $739 | $688 | $686 |
| Property Plant & Equip (Net) | $11 | $11 | $11 | $12 |
| Goodwill | $119 | $117 | $117 | $117 |
| Intangibles | $623 | $481 | $502 | $522 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $6 | $0 | $0 |
| Other NC Assets | $73 | $28 | $29 | $32 |
| Total NC Assets | $826 | $644 | $660 | $682 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,420 | $1,382 | $1,347 | $1,368 |
| Liabilities | – | – | – | – |
| Payables | $109 | $8 | $7 | $5 |
| Short-Term Debt | $0 | $7 | $6 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $222 | $271 | $269 | $281 |
| Total Curr. Liab. | $331 | $286 | $282 | $292 |
| LT Debt | $31 | $24 | $26 | $27 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $5 |
| Other NC Liab. | $8 | $8 | $7 | $8 |
| Total NC Liab. | $39 | $32 | $35 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $31 | $32 | $32 | $34 |
| Total Liabilities | $370 | $319 | $317 | $332 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $522 | $567 | $545 | $556 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $528 | $497 | $486 | $479 |
| Total Equity | $1,050 | $1,064 | $1,031 | $1,036 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,420 | $1,382 | $1,347 | $1,368 |
| Net Debt | -$120 | -$113 | -$84 | -$35 |